Patents
Patents for C07D 519 - Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups or (11,041)
04/2006
04/12/2006EP1005356B1 Novel antibacterial agents
04/12/2006CN1250554C Preparing method for nanometer powder of synthetic metal ET salt
04/12/2006CN1250553C Antidepressant azaheterocyclylmethyl derivatives of 2, 3-dihydro-1,4-dioxino [2,3-f] quinoxaline
04/06/2006US20060074251 Deoxoartemisinin analogs, process for their preparation, and anticancer agent comprising them
04/06/2006US20060074240 Process for the synthesis of derivatives of 2,3-dihydro-1,4-dioxino-[2,3-f] quinoline
04/06/2006US20060074125 Novel dithiolopyrrolones with therapeutic activity
04/06/2006US20060074064 Tricyclic 6-alkylidene-penems as beta-lactamase inhibitors
04/05/2006EP1641799A1 Imidazo-pyridazinone derivatives and imidazo-pyridone derivatives, production thereof, and use thereof as medicaments
04/05/2006EP1641453A2 Product containing at least one phosphatase cdc25 inhibitor combined with at least one other anticancer agent
04/04/2006US7022856 Carboline derivatives
04/04/2006US7022840 Porphyrin array exhibiting large two photon absorption property and including, as structural unit, bis (imidazolylporphyrin metal complex) linked with acetylenic bond and the derivative thereof, and method of producing the same
04/04/2006US7022704 5,6,7, 8-tetrahydro-imidazo-(1,2a)-pyrazine derivative; useful for treating restenosis and tumor
03/2006
03/30/2006WO2006033703A1 Imidazo[4,5-d]pyrimidines, their uses and methods of preparation
03/30/2006WO2006032380A1 Quaternary alkaloid derivatives of chelidonium majus l
03/30/2006US20060069092 Pharmaceutical compositions for the treatment of diseases related to neurotrophines
03/30/2006US20060069088 Benzoxazinyl-amidocyclopentyl-heterocyclic modulators of chemokine receptors
03/30/2006CA2593202A1 Quaternary alkaloid derivatives of chelidonium majus l
03/30/2006CA2574220A1 Imidazo[4,5-d]pyrimidines, their uses and methods of preparation
03/29/2006CN1753900A Inhibitors
03/29/2006CN1753899A Spirotetrathiocarbamates and spirooxothiocarbamates
03/29/2006CN1753895A Spiro-substituted pyrrolopyrimidines
03/29/2006CN1752090A Preparation method of ertabeinan sodium salt
03/29/2006CN1247590C Process for synthesis of derivatives of 2,3-dihydro-1,4-dioxino-[2,3-f]quinoline
03/29/2006CN1247589C Tricyclic derivatives of indole with antiangiogenic activity
03/28/2006US7019026 Modulators of Protein Tyrosine Phosphatases (PTPases)
03/28/2006US7018997 Tricyclic 6-alkylidene-penems as β-lactamase inhibitors
03/28/2006CA2219533C Process for preparing enantiomerically pure tropic acid esters
03/23/2006WO2005023819A9 Thienopyrroles as antiviral agents
03/23/2006US20060063809 Tri-substituted heteroaryls and methods of making and using the same
03/23/2006US20060063798 Heterocyclic aromatic compounds useful as growth hormone secretagogues
03/22/2006EP1637520A1 Polymethine ethers
03/22/2006EP1636235A1 Pyridinylpyrazolopyrimidinone derivatives as pde 7 inhibitors
03/22/2006EP1636233A1 Cannabinoid receptor ligands and uses thereof
03/22/2006EP1636224A2 Pyrrolopyridine-2-carboxylic acid amide inhibitors of glycogen phoshorylase
03/22/2006EP1377586B1 Tricyclic diazepines as tocolytic oxytocin receptor antagonists
03/22/2006EP1375560B1 Alkylenedioxythiophene dimers and trimers
03/22/2006EP1200433B1 C-6 RING-SUBSTITUTED PYRIDO[1,2-a]BENZIMIDAZOLE DERIVATIVES USEFUL IN TREATING CENTRAL NERVOUS SYSTEM DISORDERS
03/21/2006US7015215 Pyrrolo[2,1-c][1,4] benzodiazepines compounds and process thereof
03/21/2006CA2315220C Integrin receptor antagonists
03/16/2006WO2006029167A2 Treatment of diseases using nalmefene and its analgos
03/16/2006WO2005103003A3 Pyrrolopyridine derivatives and their use as hiv-integrase inhibitors
03/16/2006US20060058320 [1,2,4] Triazolo[1,5-c]pyrimidine derivatives
03/16/2006US20060058295 Novel compounds as pharmaceutical agents
03/16/2006DE102004038270A1 Substituierte, bizyklische 8-Amino-xanthine, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel Substituted bicyclic 8-amino-xanthine, processes for their preparation and their use as medicaments
03/16/2006DE102004038269A1 Substituierte, bizyklische 8-Piperidino-xanthine, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel Substituted bicyclic 8-piperidino xanthine, processes for their preparation and their use as medicaments
03/16/2006CA2579378A1 Treatment of diseases using nalmefene and its analogs
03/15/2006EP1633759A1 Cross-linked glycopeptide - cephalosporin antibiotics
03/15/2006EP1633758A2 Imidazothiazoles and imidazoxazole derivatives as inhibitors of p38
03/15/2006EP1633756A2 A2a adenosine receptor antagonists
03/15/2006EP1448566B1 Chemokine receptor antagonists and methods of use thereof
03/15/2006EP1309593B1 Substituted pyrazoles
03/15/2006EP1020446B1 Naphthalimidobenzamide derivatives
03/15/2006CN1747957A Intermediate for 2-substituted carbapenem derivative and production process
03/15/2006CN1747949A Acyclic pyrazole compounds
03/15/2006CN1245409C Preparation of dehydrate catharahhine from intermediate of vinorelbine synthesis
03/15/2006CN1245408C Use of Maituolaicin
03/14/2006CA2241014C Morphine derivatives with analgesic activity
03/14/2006CA2165800C Antiallergic imidazoazepines
03/09/2006WO2005014572A8 Pyrimidylpyrrole derivatives active as kinase inhibitors
03/09/2006US20060051879 Capture compounds, collections thereof and methods for analyzing the proteome and complex compositions
03/08/2006EP1631569A2 Quinuclidine derivatives binding to mucarinic m3 receptors
03/08/2006CN1745081A Dihydropteridinones, method for the production and use thereof in the form of drugs
03/07/2006US7008944 Treating obsessive compulsive disorder, panic attacks, sexual disorders, eating disorders, obesity, drug abuse and ethanol or cocaine dependence; anxiolytic agents
03/01/2006EP1628978A2 Triaza-spiro compounds as nociceptin analogues and uses thereof
03/01/2006EP1363910B1 Methods of treating p38 kinase-associated conditions and pyrrolotriazine compounds useful as kinase inhibitors
03/01/2006EP1319007B1 Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function
03/01/2006CN1742013A Pyrazolopyrimidine compound and method for producing the same
02/2006
02/28/2006USRE38994 Pyropheophorbides conjugates and their use in photodynamic therapy
02/23/2006WO2006001511A8 Pyrrolopyrimidine and pyrrolopyridine derivatives substituted with a cyclic amino group as crf antagonists
02/23/2006US20060041123 Antibacterial agents
02/23/2006US20060040964 Eating disorders; psychological disorders; antidiabetic agents; cardiovascular disorders
02/23/2006US20060040957 Bicyclic pyrimidine matrix metalloproteinase inhibitors
02/23/2006US20060040940 Imidazopyridines pyrimidines and triazines for enhancing cognition as gaba-a-alphas 5 receoptor subtype ligands
02/23/2006US20060040925 Aminocyclohexene quinolines and their azaisosteric analogues with antibacterial activity
02/23/2006CA2567782A1 Heterocyclic condensed compounds useful as antidiuretic agents
02/22/2006EP1627876A1 Heterocyclic condensed compounds useful as antidiuretic agents
02/22/2006EP1626972A1 PROCESS FOR SYNTHESIZING ß-LACTAMASE INHIBITOR INTERMEDIATES
02/21/2006US7001982 Non-natural C-linked carbo-β-peptides with robust secondary structures
02/21/2006US7001911 Fused cyclic modulators of nuclear hormone receptor function
02/21/2006US7001900 Central nervous system disorders
02/21/2006US7001677 Electroluminescent devices comprising diketopyrrolopyrroles
02/16/2006WO2006017672A2 2, 8-disubstituted naphthyridine derivatives
02/16/2006WO2006015701A1 Substituted, bicyclic 8-pyrrolidinoxanthines, method for the production thereof and their use as medicaments
02/16/2006WO2006015700A1 Substituted, bicyclic 8-piperidinoxanthines, method for the production thereof and their use as medicaments
02/16/2006WO2005042475A3 Carbamoyl esters that inhibit cholinesterase and release pharmacologically active agents
02/16/2006US20060035920 Chk-1 inhibitors
02/16/2006CA2576096A1 Substituted, bicyclic 8-pyrrolidinoxanthines, method for the production thereof and their use as medicaments
02/16/2006CA2576090A1 Substituted bicyclic 8-pyrrolidino-xanthines and use thereof as inhibitors of the dipeptidyl peptidase iv
02/16/2006CA2575571A1 2,8-disubstituted naphthyridine derivatives
02/15/2006EP1625128A2 Thermal energy storage
02/15/2006CN1735617A Quinazoline derivatives as SRC tyrosine kinase inhibitors
02/15/2006CN1735615A Methods for the preparation of pyrrolotriazine compounds useful as kinase inhibitors
02/15/2006CN1735612A Anti-infective agents
02/15/2006CN1733762A Acid absorbing agent for preparing cinchona alkaloids ligand
02/15/2006CN1733722A Bis-heterocyclic compounds with antitumour and chemosensitising activity
02/14/2006US6998487 Structure including at least three planar moieties, which are linearly configured such that one planar moiety is located between two neighboring planar moieties and shares an atom with each of the moieties
02/08/2006EP1622904A1 Cannabinoid receptor ligands and uses thereof
02/07/2006CA2262454C Purine inhibitors of cyclin dependent kinase 2 and ikb-.alpha.
02/02/2006US20060025411 Methods for treating diseases or conditions using dihydropteridinone compounds
02/02/2006US20060024775 Substrates for o6-alkylguanina-dna alkyltransferase
1 ... 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 ... 111